FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 39 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90,439 | -33.8% | 31,733 | +69.1% | 0.00% | – |
| Q4 2022 | $136,631 | -28.8% | 18,768 | -20.9% | 0.00% | – |
| Q3 2022 | $192,000 | +82.9% | 23,730 | +10.6% | 0.00% | – |
| Q2 2022 | $105,000 | -82.4% | 21,450 | -15.2% | 0.00% | – |
| Q1 2022 | $598,000 | +23.6% | 25,299 | -7.6% | 0.00% | – |
| Q4 2021 | $484,000 | -53.1% | 27,387 | -25.2% | 0.00% | – |
| Q3 2021 | $1,032,000 | +647.8% | 36,595 | +178.3% | 0.00% | – |
| Q2 2021 | $138,000 | +17.9% | 13,150 | +32.2% | 0.00% | – |
| Q1 2021 | $117,000 | -7.9% | 9,947 | -8.2% | 0.00% | – |
| Q4 2020 | $127,000 | +104.8% | 10,838 | +38.5% | 0.00% | – |
| Q3 2020 | $62,000 | -47.0% | 7,827 | +22.1% | 0.00% | – |
| Q2 2020 | $117,000 | +108.9% | 6,410 | +38.3% | 0.00% | – |
| Q1 2020 | $56,000 | +124.0% | 4,636 | +207.0% | 0.00% | – |
| Q4 2019 | $25,000 | +257.1% | 1,510 | +25.7% | 0.00% | – |
| Q3 2019 | $7,000 | – | 1,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
| TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
| Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
| COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
| VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
| RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
| RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |